Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31038120 | 0.98 | FAAH (0.55) | MAOAFAAHCES1MAOBSIGMAR1 | |
| SCHEMBL28037433 | 0.98 | FAAH (0.55) | MAOAFAAHCES1MAOBSIGMAR1 | |
| SCHEMBL8082932 | 0.93 | FAAH (0.48) | MAOAFAAHCES1MAOBSIGMAR1 | |
| SCHEMBL20563012 | 0.91 | FAAH (0.47) | MAOAFAAHCES1MAOBSIGMAR1 | |
| SCHEMBL17388609 | 0.87 | FAAH (0.44) | MAOAFAAHCES1MAOBSIGMAR1 | |
| SCHEMBL144712 | 0.83 | ALDH1A1 (0.48) | MAOAFAAHCES1MAOBL3MBTL1 | |
| SCHEMBL7931693 | 0.83 | FFAR1 (0.49) | FAAH | |
| SCHEMBL28303524 | 0.83 | FAAH (0.49) | MAOAFAAHCES1MAOBSIGMAR1 | |
| SCHEMBL17288540 | 0.83 | FAAH (0.49) | MAOAFAAHCES1MAOBSIGMAR1 | |
| SCHEMBL17288637 | 0.81 | FAAH (0.51) | MAOAFAAHCES1MAOBSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912949-A | Liquid crystal composition and element thereof | 上海隆昇光电新材料有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-20200356000-A9 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2020-11-12 | — | — | US | disclosed |
| US-20190354010-A1 | RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMING METHOD | JSR CORPORATION (JP) | 2019-11-21 | — | — | US | disclosed |
| US-20190310551-A1 | RADIATION-SENSITIVE COMPOSITION, PATTERN-FORMING METHOD AND METAL OXIDE | JSR CORPORATION (JP) | 2019-10-10 | — | — | US | disclosed |
| US-8110575-B2 | Compounds | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-02-07 | — | — | US | disclosed |
| US-20110021500-A1 | NOVEL COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-01-27 | — | — | US | disclosed |
| EP-0674651-A1 | SUBSTITUTED 6-AZAANDROSTENONES | GLAXO WELLCOME INC. (US) | 1995-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021500-A1 | NOVEL COMPOUNDS | CALCRL, CALCR, CALCA | MAOA 875/4885FAAH 1015/4885CES1 2293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.